MedPath

Hyoscyamine

Hyoscyamine Sulfate Extended-Release Tablets, 0.375 mg Rx only

Approved
Approval ID

5bbce8c0-a9c9-45b9-8457-1542bd3d9449

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Apr 11, 2016

Manufacturers
FDA

Wallace Pharmaceuticals Inc.

DUNS: 962531955

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

hyoscyamine sulfate

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code51525-0115
Product Classification
G
Generic Name
hyoscyamine sulfate
Product Specifications
Route of AdministrationORAL
Effective DateApril 11, 2016
FDA Product Classification

INGREDIENTS (1)

HYOSCYAMINE SULFATEActive
Quantity: 0.375 mg in 1 1
Code: F2R8V82B84
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Hyoscyamine - FDA Drug Approval Details